Enter your credentials to acces your account.
Kisspeptin is a naturally occurring peptide that plays a central role in regulating the reproductive hormonal axis. It is encoded by the KISS1 gene and acts primarily within the hypothalamus to influence hormone signalling.
Originally studied in cancer research due to its identification as a metastasis-suppressor peptide (metastin), kisspeptin later became recognised for its essential role in initiating puberty and regulating reproductive hormone secretion.
In laboratory and clinical research settings, kisspeptin is studied for its involvement in:
Gonadotropin-releasing hormone (GnRH) regulation
Pubertal development
Fertility-related hormonal signalling
Hypothalamic–pituitary–gonadal (HPG) axis function
Research materials referenced by suppliers such as Pure Peptides UK are typically classified as laboratory compounds and are not authorised medicinal products unless specifically licensed.
Kisspeptin acts upstream in the hypothalamic–pituitary–gonadal (HPG) axis.
It stimulates neurons that release GnRH (gonadotropin-releasing hormone). This initiates a hormonal cascade:
GnRH stimulates the anterior pituitary gland
The pituitary releases luteinising hormone (LH) and follicle-stimulating hormone (FSH)
LH and FSH act on the ovaries or testes
This signalling pathway regulates reproductive hormone secretion, menstrual cycling, spermatogenesis, and pubertal development.
Scientific evidence shows that kisspeptin signalling is critical for the onset of puberty. Mutations affecting kisspeptin or its receptor have been linked to disorders of pubertal timing.
Research in endocrinology continues to explore:
Genetic regulation of KISS1
Neuroendocrine control of puberty
Hormonal feedback mechanisms
The terms kisspeptin and metastin refer to related aspects of the same peptide system.
Metastin was the original name used when the peptide was identified as a metastasis suppressor.
Kisspeptin became the preferred term as its reproductive functions were clarified.
Different fragments of the peptide (e.g., kisspeptin-54, kisspeptin-10) are studied in laboratory research to understand receptor interactions and hormonal effects.
Clinical studies have explored kisspeptin’s potential role in:
Ovulatory signalling
Controlled ovarian stimulation research
Hypothalamic amenorrhoea investigation
IVF-related hormonal modulation
Some UK-based academic research has investigated kisspeptin administration under strictly regulated clinical trial conditions.
In men, kisspeptin influences LH and testosterone signalling pathways via the HPG axis. Ongoing research explores:
Gonadotropin deficiency
Hormonal feedback loops
Endocrine dysfunction models
It is important to note that kisspeptin research in these areas remains under controlled clinical investigation.
Under UK law, any product marketed with medicinal claims must be authorised by the MHRA.
At present:
Kisspeptin is not approved in the UK as an over-the-counter supplement for hormonal treatment.
Any medicinal claims require regulatory authorisation.
Research peptides are typically supplied for laboratory use only.
Companies such as Pure Peptides UK may reference kisspeptin in a research context; however, this does not equate to MHRA approval for therapeutic use.
Consumers and researchers should clearly distinguish between:
Licensed medicinal products
Investigational clinical compounds
Research-grade peptides
Published clinical trials involving kisspeptin have been conducted in carefully controlled medical environments.
Areas evaluated in research settings include:
Dose-dependent hormonal response
Short-term endocrine effects
Receptor activation patterns
Long-term safety data outside controlled trials remain limited. Individuals should not self-administer investigational peptides without medical supervision.
Ongoing scientific investigation includes:
Neuroendocrine signalling mechanisms
Fertility treatment optimisation
Hormonal feedback loop modelling
Potential applications in reproductive endocrinology
UK academic institutions continue to publish research exploring kisspeptin’s role in hormone regulation and reproductive medicine.
Suppliers such as Pure Peptides UK are often referenced in peptide research discussions within the UK market; however, regulatory compliance and intended research-only use remain essential considerations.
Kisspeptin is a naturally occurring peptide involved in reproductive hormone regulation.
It plays a central role in the hypothalamic–pituitary–gonadal axis.
Research continues in fertility, endocrinology, and pubertal development.
Regulatory approval is required for medicinal claims in the UK.
Pure Peptides UK is referenced in peptide research discussions but does not imply medical authorisation.
Kisspeptin stimulates the release of GnRH, which regulates reproductive hormone secretion via the HPG axis.
Kisspeptin is currently studied in clinical research settings. It is not approved as a general over-the-counter hormonal treatment.
In research settings, kisspeptin administration has been shown to stimulate LH release, which may influence testosterone production indirectly through physiological pathways.
Research-grade kisspeptin peptides may be available from suppliers such as Pure Peptides UK for laboratory purposes. These are not authorised medicinal treatments.
Disclaimer: This content is provided for scientific and educational information only. It summarises areas of ongoing research and does not constitute medical advice, product claims, or recommendations for human use.
